Sternal-Sparing Surgical Options in Combined Aortic Valve and Coronary Artery Disease: Proof of Concept
Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery · 2023
DOI: 10.1177/15569845231185566 ↗Kurz gefasst
Fachartikel in der Zeitschrift Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 2023. Verfasst von Tatsuya Watanabe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardiac Surgery, Department of Surgery, University of Chicago Medicine, IL, USA. Hauptthemen laut MEDLINE: Coronary Artery Disease, Aortic Valve Stenosis, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Objective
The standard management of concomitant aortic valve (AV) and coronary artery disease has been coronary artery bypass and AV replacement (AVR). With the advent of minimally invasive options, many isolated lesions have been successfully managed using a sternal-sparing approach. In our institution, patients with isolated AV disease are offered minimally invasive surgical or transcatheter AVR, and those with isolated coronary artery disease are routinely managed with robotic totally endoscopic coronary artery bypass or percutaneous coronary intervention. Various combinations of these techniques can be used when a sternal-sparing posture is desired because of patient risk or preference. The aim of this study was to review the outcomes in patients with combined AV and coronary disease who were managed using sternal-sparing approaches.
Methods
We reviewed the records of 10 patients in our minimally invasive surgical database who presented with concomitant AV and coronary artery disease and underwent combined sternal-sparing management of these 2 lesions using various combinations of minimally invasive approaches.
Results
Four patients had totally endoscopic coronary artery bypass and minimally invasive AVR at the same time, 2 patients underwent transcatheter AVR followed by totally endoscopic coronary artery bypass, and 4 patients underwent minimally invasive AVR with percutaneous coronary intervention. There was no 30-day mortality. The duration of postoperative surgical hospital stay was 3.1 ± 0.9 days.
Conclusions
Sternal-sparing approaches in combined AV and coronary artery disease are feasible with patient-specific treatment selection of minimally invasive techniques.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Cardiac Surgery, Department of Surgery, University of Chicago Medicine, IL, USA.
- Division of Cardiology University of Chicago Medicine, IL, USA.
ORCID-Profile: Tatsuya Watanabe, Husam H Balkhy
Zitieren
APA
Watanabe, T., Kitahara, H., Shah, A. P., Blair, J., Nathan, S., & Balkhy, H. H. (2023). Sternal-Sparing Surgical Options in Combined Aortic Valve and Coronary Artery Disease: Proof of Concept. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. https://doi.org/10.1177/15569845231185566
Vancouver
Watanabe T, Kitahara H, Shah AP, Blair J, Nathan S, Balkhy HH. Sternal-Sparing Surgical Options in Combined Aortic Valve and Coronary Artery Disease: Proof of Concept. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 2023. doi:10.1177/15569845231185566
BibTeX
@article{Watanabe2023,
author = {Watanabe, Tatsuya and Kitahara, Hiroto and Shah, Atman P and Blair, John and Nathan, Sandeep and Balkhy, Husam H},
title = {Sternal-Sparing Surgical Options in Combined Aortic Valve and Coronary Artery Disease: Proof of Concept},
journal = {Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery},
year = {2023},
doi = {10.1177/15569845231185566}
}
EUVIMED